In recent years, totally implantable vascular access devices (TIVADs) are widely used for infusion of high-concentration chemotherapeutic drugs and total parenteral nutrition solution, mainly in cancer patients. While there is no definite optimal time and detailed surgical procedures for the removal of TIVADs. The purpose of the study was to investigate the effects and complications of different removal approaches of totally implantable vascular access devices (TIVADs). A retrospective analysis

more »

... was performed on 205 breast cancer patients who underwent TIVAD removal between June 2019 and November 2019. The patients were randomly divided into two groups. There were 102 cases in group A, in which the port was removed before the catheter. There were 103 cases in group B, in which the catheter was removed before the port. The systematic analysis focused on operation time and postoperative complications (pain, local skin infection, and hematoma). There were no significant differences in postoperative pain, wound infection, and hematoma between the two groups (P>0.05). The operation time was significantly shortened in group A (P<0.01).There were no significant differences in postoperative complications between the two groups. The operation time could be significantly reduced by adopting the strategy of removing the port before the catheter.